| Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study R Bhopal, N Unwin, M White, J Yallop, L Walker, K Alberti, J Harland, ... Bmj 319 (7204), 215-220, 1999 | 793 | 1999 |
| A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon TI Verhoef, G Ragia, A de Boer, R Barallon, G Kolovou, V Kolovou, ... New England Journal of Medicine 369 (24), 2304-2312, 2013 | 262 | 2013 |
| Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome A Vryonidou, A Papatheodorou, A Tavridou, T Terzi, V Loi, IA Vatalas, ... The Journal of Clinical Endocrinology & Metabolism 90 (5), 2740-2746, 2005 | 230 | 2005 |
| Genetic polymorphisms of drug‐metabolizing enzymes CYP2D6, CYP2C9, CYP2C19 and CYP3A5 in the Greek population K Arvanitidis, G Ragia, M Iordanidou, S Kyriaki, A Xanthi, A Tavridou, ... Fundamental & clinical pharmacology 21 (4), 419-426, 2007 | 188 | 2007 |
| Presence of CYP2C9* 3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas G Ragia, I Petridis, A Tavridou, D Christakidis, VG Manolopoulos Pharmacogenomics 10 (11), 1781-1787, 2009 | 117 | 2009 |
| The association of adipokine levels in plasma and synovial fluid with the severity of knee osteoarthritis C Staikos, A Ververidis, G Drosos, VG Manolopoulos, DA Verettas, ... Rheumatology 52 (6), 1077-1083, 2013 | 115 | 2013 |
| Pharmacogenetics of coumarinic oral anticoagulants VG Manolopoulos, G Ragia, A Tavridou Pharmacogenomics 11 (4), 493-496, 2010 | 97 | 2010 |
| Need for reassessment of reported CYP2C19 allele frequencies in various populations in view of CYP2C19* 17 discovery: the case of Greece G Ragia, KI Arvanitidis, A Tavridou, VG Manolopoulos Future Medicine Ltd 10 (1), 43-49, 2009 | 91 | 2009 |
| Pharmacogenomics of oral antidiabetic medications: current data and pharmacoepigenomic perspective VG Manolopoulos, G Ragia, A Tavridou Pharmacogenomics 12 (8), 1161-1191, 2011 | 87 | 2011 |
| The serotonin transporter promoter polymorphism (5-HTTLPR) is associated with type 2 diabetes M Iordanidou, A Tavridou, I Petridis, KI Arvanitidis, D Christakidis, ... Clinica Chimica Acta 411 (3-4), 167-171, 2010 | 83 | 2010 |
| New aspects on the metabolic role of intestinal microbiota in the development of atherosclerosis I Drosos, A Tavridou, G Kolios Metabolism 64 (4), 476-481, 2015 | 66 | 2015 |
| Carotid intima-media thickness is an independent predictor of all-cause mortality and cardiovascular morbidity in patients with diabetes mellitus type 2 and chronic kidney disease A Roumeliotis, S Roumeliotis, S Panagoutsos, M Theodoridis, C Argyriou, ... Renal failure 41 (1), 131-138, 2019 | 55 | 2019 |
| Endothelial nitric oxide synthase gene polymorphisms -786T >C and 894G >Tin coronary artery bypass graft surgery patients G Ragia, E Nikolaidis, A Tavridou, KI Arvanitidis, S Kanoni, GV Dedoussis, ... Human genomics 4, 1-9, 2010 | 49 | 2010 |
| Pharmacological characterization in vitro of EP2306 and EP2302, potent inhibitors of squalene synthase and lipid biosynthesis A Tavridou, L Kaklamanis, G Megaritis, AP Kourounakis, A Papalois, ... European journal of pharmacology 535 (1-3), 34-42, 2006 | 47 | 2006 |
| Serum concentrations of vitamins A and E in impaired glucose tolerance A Tavridou, NC Unwin, MF Laker, M White, KGMM Alberti Clinica chimica acta 266 (2), 129-140, 1997 | 47 | 1997 |
| Antioxidant effects of simvastatin in primary and secondary prevention of coronary heart disease A Tavridou, A Efthimiadis, I Efthimiadis, H Paschalidou European journal of clinical pharmacology 62, 485-489, 2006 | 44 | 2006 |
| Vitamin D receptor ApaI a allele is associated with better childhood asthma control and improvement in ability for daily activities M Iordanidou, E Paraskakis, E Giannakopoulou, A Tavridou, G Gentile, ... Omics: a journal of integrative biology 18 (11), 673-681, 2014 | 42 | 2014 |
| Matrix Gla protein T-138C polymorphism is associated with carotid intima media thickness and predicts mortality in patients with diabetic nephropathy S Roumeliotis, A Roumeliotis, S Panagoutsos, E Giannakopoulou, ... Journal of Diabetes and its Complications 31 (10), 1527-1532, 2017 | 41 | 2017 |
| No impact of SLCO1B1 521T>C, 388A>G and 411G>A polymorphisms on response to statin therapy in the Greek population E Giannakopoulou, G Ragia, V Kolovou, A Tavridou, AD Tselepis, ... Molecular biology reports 41, 4631-4638, 2014 | 40 | 2014 |
| EP2306 [2-(4-biphenyl)-4-methyl-octahydro-1, 4-benzoxazin-2-ol, hydrobromide], a novel squalene synthase inhibitor, reduces atherosclerosis in the cholesterol-fed rabbit A Tavridou, L Kaklamanis, A Papalois, AP Kourounakis, EA Rekka, ... Journal of Pharmacology and Experimental Therapeutics 323 (3), 794-804, 2007 | 38 | 2007 |
